Stock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO

Stock Track

2024-10-12

Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).

Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.

The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1153411982"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153411982\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1153411982?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-12 00:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153411982","market":"hk","top_or_hot":-1,"title":"Stock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO","media":"Stock Track","content":"<p>Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).</p>\n\n<p>Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.</p>\n\n<p>The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-10-12 00:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).</p>\n\n<p>Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.</p>\n\n<p>The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAMP","symbol_name":"Camp4 Therapeutics Corp.","start_time":0,"source_url":"","article_id":"1153411982","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153411982","pubTimestamp":1728663020,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Camp4 Therapeutics Corp.  skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering .Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CAMP":"Camp4 Therapeutics Corp."},"translate_title":"股票轨迹Camp4 Therapeutics IPO 7500万美元后首次交易飙升2690%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAMP":1},"content_text":"Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).\nCamp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.\nThe robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}